IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
Operating Income
IDEXX Laboratories Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Operating Income
$1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
47%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is IDEXX Laboratories Inc's Operating Income?
Operating Income
1.1B
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Operating Income amounts to 1.1B USD.
What is IDEXX Laboratories Inc's Operating Income growth rate?
Operating Income CAGR 10Y
15%
Over the last year, the Operating Income growth was 20%. The average annual Operating Income growth rates for IDEXX Laboratories Inc have been 12% over the past three years , 17% over the past five years , and 15% over the past ten years .